PlainRecalls
FDA Drug Low Class III Terminated

VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30

Reported: January 4, 2017 Initiated: December 12, 2016 #D-0241-2017

Product Description

VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30

Reason for Recall

cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.

Details

Units Affected
124,250 bottles
Distribution
Nationwide
Location
Nashville, TN

Frequently Asked Questions

What product was recalled?
VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30. Recalled by VIRTUS PHARMACEUTICALS OPCO II L. Units affected: 124,250 bottles.
Why was this product recalled?
cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 4, 2017. Severity: Low. Recall number: D-0241-2017.